This page includes the latest FDA filings for Akcea Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | AKCA | DUNS 079911419 |
Device Company | Device | Date |
---|---|---|
Akcea Therapeutics, Inc. | Other Medication | 2023-05-26 |
Akcea Therapeutics, Inc. | Other Medication | 2023-05-19 |
Akcea Therapeutics, Inc. | Prescription Medication | 2023-01-12 |
Akcea Therapeutics, Inc. | Prescription Medication | 2022-07-02 |
Akcea Therapeutics, Inc. | Prescription Medication | 2021-08-14 |
Akcea Therapeutics, Inc. | Prescription Medication | 2020-08-29 |
Akcea Therapeutics, Inc. | Prescription Medication | 2020-08-06 |
Akcea Therapeutics, Inc. | Prescription Medication | 2019-12-05 |
Akcea Therapeutics, Inc. | Prescription Medication | 2019-06-22 |
Akcea Therapeutics, Inc. | Prescription Medication | 2019-05-29 |
Akcea Therapeutics, Inc. | Tegsedi | 2018-10-05 |
NCAGE Code | 897W4 | AKCEA THERAPEUTICS, INC.!DBA AKCEA THERAPEUTICS |
CAGE Code | 897W4 | AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS |
S.A.M. Registration | 897W4 [79911419] | AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS |
S.A.M. Registration | 897W4 [79911419] | AKCEA THERAPEUTICS, INC. AKCEA THERAPEUTICS |
DUNS | 079911419 | Akcea Therapeutics, Inc. |
SEC | 0001662524 | AKCEA THERAPEUTICS, INC. of DELAWARE |